MEDINET Co.,Ltd. (2370)

Price history

¥22Latest-60.7%

Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis

Business overview

A summary lands here once the filings have been read.

Recurring subjects

No threads yetThis company's filings have not been read yet. We are adding them progressively.

Companies sharing a theme

Documents

See all timely disclosures See all statutory filings

News

See all news

Key numbersShowing 8 of 17

PER

406.35How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.

PBR

1.83How many times the company's net assets? Around 1x is generally considered a benchmark.

ROE

-24.9%Earning power. A figure above 10% is generally considered good.

Dividend yield

0.0%The annual dividend as a percentage of the share price.

Market capitalization

¥6.2bnShare price × number of shares. The value of the entire company.

Equity ratio

89.4%The proportion of assets funded by money that does not have to be repaid.

Operating margin

-152.5%The percentage of revenue remaining from the company’s core business.

Revenue growth (3 years)

7.4%The average annual growth in sales over the past three years.

What to watch next

MDNT-01 (NeoCart®): Japan development policy and progress, including specific updates on clinical trials and manufacturing arrangements

Impact HighLikelihood Medium

Expansion in revenue and profitability from S-DSC® contract manufacturing, including more specific quarterly segment contributions

Impact MediumLikelihood Medium

Transition of contract ASC manufacturing to the execution phase, including disclosures on the start of contract manufacturing, facilities and regulatory approvals, and customer acquisition

Impact MediumLikelihood Low

Progress on the major capital investment plan for the Shinagawa CPF facility and updates on the expected completion outlook, which remains undetermined

Impact LowLikelihood Low

The latest status of financing, including stock acquisition rights, and progress in improving operating results, including the extent to which the policy of returning to profitability is being achieved

Impact HighLikelihood Medium

What to watch next

Who owns itTop holders total 10.6%

Listed holders 10.6%Everyone else 89.4%

楽天証券株式会社3.36%

Kimura Yoshiji (木村佳司)2.97%

株式会社ＳＢＩ証券0.71%

廣瀬成留0.67%

J.P. Morgan Securities Co., Ltd.0.56%

森部鐘弘0.52%

和賀賢太郎0.49%

西尾徳成0.45%

2 other listed holders0.85%

Who owns it
Holder	Ownership (%)
楽天証券株式会社	3.36
Kimura Yoshiji (木村佳司)	2.97
株式会社ＳＢＩ証券	0.71
廣瀬成留	0.67
J.P. Morgan Securities Co., Ltd.	0.56
森部鐘弘	0.52
和賀賢太郎	0.49
西尾徳成	0.45
2 other listed holders	0.85

This company's documents

Filings

Timely disclosures

Threads